Latest Property Portfolio News

Hazer Group has reported a remarkable FY25 performance with revenues more than doubling and losses slashed by 60%, underpinned by a strategic partnership with KBR and early commercial revenues.

Hazer Group Limited reported a 124% surge in revenues to $8.5 million for FY25, driven by government grants, while cutting its net loss by 60%. The company advanced its proprietary methane pyrolysis technology, secured a strategic alliance with KBR, and made progress on key projects in Canada and Japan.

Neurizon Therapeutics reported a $16.6 million loss for FY2025 amid significant progress in its lead neurodegenerative therapy NUZ-001, including regulatory milestones and a global licensing deal. The company is poised to enter a pivotal ALS clinical trial pending FDA clearance.

Scentre Group reported a 93% surge in half-year profit to $782.2 million, driven by strong operational growth and property valuation gains. The Group declared an interim distribution of 8.815 cents per security and reaffirmed its 2025 growth guidance.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Actinogen Medical reported a $14.7 million net loss for FY25 while progressing its lead drug Xanamem through pivotal Alzheimer’s and depression trials, with interim results expected in January 2026. The company has secured funding through mid-2026 and is preparing for commercialization.

K&S Corporation reported a 9% decline in underlying profit before tax for FY2025, alongside a 9.7% drop in revenue, as it invests heavily in property and terminal upgrades while navigating safety regulatory pressures.

Clime Capital Limited reported a 29% drop in net profit for FY25 but maintained its quarterly dividends and rolled over convertible notes with enhanced terms. The company is pivoting towards a debt-focused portfolio to boost income stability.

Abacus Group has reversed last year’s losses to post a $26.9 million statutory profit in FY25, maintaining its distribution and signalling confidence for FY26 despite market challenges. The group’s commercial portfolio shows resilience, supported by a strategic stake in Abacus Storage King and ongoing capital management.

Abacus Group delivered a strong FY25 result with a significant profit increase and steady distributions, underpinned by resilient office and retail portfolios and a strategic focus on capital partnering.

Abacus Group (ASX – ABG) reported a strong turnaround in FY25 with a net profit of $26.9 million and a 35.6% rise in revenue, maintaining steady distributions while navigating a strategic stake in Abacus Storage King amid an acquisition proposal.

EVT Group has released an extensive valuation update on its diversified $2.3 billion property portfolio, spotlighting landmark Sydney CBD assets alongside a broad hospitality and entertainment footprint across Australia, New Zealand, and Germany.